Practice Economics

Docs to CMS: Delay Meaningful Use Stage 3


 

References

But Dr. Rocky D. Bilhartz, an interventional cardiologist in private practice in College Station, Tex., does not believe that the AMA’s recommendations nor other changes to the meaningful use program will make it better.

“I think they’re going about this entirely the wrong way,” said Dr. Bilhartz who blogs at bilhartzmd.com. “Meaningful use should not be delayed, but frankly abandoned. I don’t necessarily believe that the Department of Health & Human Service set out to try to design a system that would impair a physician’s ability to care for patients. I do believe without a doubt, that is exactly what has happened.”

agallegos@frontlinemedcom.com

On Twitter @legal_med

Pages

Recommended Reading

Cigna CEO David Cordani: ACA marketplace is still in ‘version 1.0’
MDedge Dermatology
Survey finds malpractice concerns increase dermatopathologist use of tests, recuts
MDedge Dermatology
Medicare audits: What leads to an exclusion?
MDedge Dermatology
Teledermatology boom raises questions about proper practices
MDedge Dermatology
Creating an Action Plan for Eczema Patients
MDedge Dermatology
Documentation for Mohs Surgery
MDedge Dermatology
Oral contraception and medical liability
MDedge Dermatology
A Review of Patient Adherence to Topical Therapies for Treatment of Atopic Dermatitis
MDedge Dermatology
Benchmarks are coming
MDedge Dermatology
NIH, CDC get boost in House budget bill
MDedge Dermatology